CAPG and breast cancer: Multivariate analysis also demonstrated that high CAPG expression (HR=3.348; 95% CI: 1.029-10.894; p=0.045) and tumor stage (HR=1.888; 95% CI: 1.151-3.094; p=0.005) were independent unfavorable prognostic factors for DFS in BC patients and only tumor stage (HR=2.728; 95% CI: 1.475-5.043; p=0.001) and axillary lymph node stage (HR=2.087; 95% CI: 1.417-3.047; p<0.001) were independent unfavorable prognostic factors for OS in BC patients (Table S2).